In the title compound, C 10 H 9 FN 2 O 4 , the dihedral angle between the benzene ring and the nitro group plane is 11.29 (3) . The morpholinone ring adopts a twist-chair conformation. In the crystal, molecules are linked by intermolecular C-HÁ Á ÁO hydrogen bonds into a chain along the aaxis direction.
Related literature
The title compound is an intermediate in the preparation of derivatives of the factor Xa inhibitor rivaroxaban (systematic name (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl}thiophene-2-carboxamide). For the bioactivity and applications of rivaroxaban, see: Pinto et al. (2010) ; Haas (2008) ; Squizzato et al. (2009) ; Samama & Gerotziafas (2010) ; Van Huis et al. (2009) . For the synthesis of other derivatives with morpholone, see: Van Huis et al. (2009); Zbinden et al. (2009) Table 1 Hydrogen-bond geometry (Å , ). Data collection: RAPID-AUTO (Rigaku, 1998) ; cell refinement: RAPID-AUTO; data reduction: RAPID-AUTO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: CrystalStructure Rivaroxaban is an oral, direct factor Xa inhibitor for the prevention and treatment of arterial and venous thrombosis (Pinto et al., 2010; Haas, 2008; Squizzato et al., 2009 ).
The title compound (Fig. 1) is important intermediate in the preparation of derivatives of Rivaroxaban. Some derivatives of Rivaroxaban have been reported for having high affinity for human FXa (Squizzato et al., 2009; Samama et al., 2010; Van Huis et al., 2009) . Herein, the synthesis and the crystal structure of the title compound are reported.
In the title compound, C 10 H 9 F 1 N 2 O 4 , the dihedral angle between benzene ring and the plane of nitro group is 11.29 (3)°.
The morpholone ring adopts a twist-chair conformation. In the crystal packing molecules are linked by intermolecular C-H···O hydrogen bonds into a chain (Table 1) .
Experimental
Potassium carbonate (6.73 g, 0.0488 mol) was added to a suspension of 2-(2-chloroethoxy)-N-(3-fluoro-4nitrophenyl)acetamide (9.00 g, 0.0325 mol) in acetonitrile (200 mL).The reaction mixture was stirred at 385 K for 5 h.
The mixture was evaporated in vacuo. Water was added.The reaction mixture was filtered, washed with water, and dried to obtain yellow solid (7.19 g).Colourless single crystals suitable for X-ray diffraction were obtained by recrystallisation from ethanol and ethyl acetate.
Refinement
All H atoms were geometrically positioned (C-H 0.95-0.99 Å) and treated as riding, with U iso (H) = 1.2Ueq(C). Fig. 1 . The structure of C 10 H 9 F 1 N 2 O 4 with all non-H atom-labelling scheme and displacement ellipsoids drawn at the 50% probability level.
Figures

4-(3-Fluoro-4-nitrophenyl)morpholin-3-one
Crystal data Hall symbol: -P 1 Mo Kα radiation, λ = 0.71073 Å a = 6.6408 (7) Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. supplementary materials sup-6 Fig. 1 
